Total Return Level Chart

Historical Total Return Level Data

View and export this data back to 2014. Start Trial.
Date Value
October 13, 2026 11.78
October 12, 2026 11.96
October 09, 2026 11.78
October 08, 2026 11.48
October 07, 2026 11.09
October 06, 2026 11.10
October 05, 2026 11.08
October 02, 2026 10.84
October 01, 2026 10.81
September 30, 2026 11.11
September 29, 2026 10.99
September 28, 2026 11.09
September 25, 2026 11.04
September 24, 2026 11.16
September 23, 2026 11.22
September 22, 2026 10.69
September 21, 2026 10.69
September 18, 2026 10.60
September 17, 2026 10.56
September 16, 2026 10.29
September 15, 2026 10.44
September 14, 2026 10.44
September 11, 2026 10.50
September 10, 2026 10.50
September 09, 2026 10.48
Date Value
September 08, 2026 10.81
September 04, 2026 11.34
September 03, 2026 11.34
September 02, 2026 11.44
September 01, 2026 11.44
August 31, 2026 11.22
August 28, 2026 10.93
August 27, 2026 11.04
August 26, 2026 11.28
August 25, 2026 11.28
August 24, 2026 11.04
August 21, 2026 10.88
August 20, 2026 9.955
August 19, 2026 9.98
August 18, 2026 9.732
August 17, 2026 9.64
August 14, 2026 9.542
August 13, 2026 9.32
August 12, 2026 9.245
August 11, 2026 9.03
August 10, 2026 9.03
August 07, 2026 9.09
August 06, 2026 9.18
August 05, 2026 9.18
August 04, 2026 9.18

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
Evaxion AS 2.76
Genmab A/S 36.57
Ascendis Pharma A/S 223.21
Zealand Pharma A/S 34.86
Agenus, Inc. 6.95